Crinetics Pharmaceuticals (CRNX) Interest & Investment Income (2017 - 2026)
Crinetics Pharmaceuticals' Interest & Investment Income came in at $12.03 million for Q2 2026, down 10.6% from $13.46 million a year earlier and down 5.0% from the prior quarter.
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) Interest & Investment Income (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Crinetics Pharmaceuticals reported Interest & Investment Income of $48.39 million, down 9.8% year-over-year; for FY2025, it was $51.99 million, up 25.5% from FY2024.
- Interest & Investment Income has increased in each of the last three years, with a five-year compound annual growth rate of 120.8% (FY2020 to FY2025).
- Going back by year, Interest & Investment Income was $41.44 million in FY2024 (+208.4%), $13.44 million in FY2023 (+211.2%), $4.32 million in FY2022 and $157,000 in FY2021 (-84.2%).
- The five-year range for quarterly Interest & Investment Income is $24,000 (Q3 2021) to $14.83 million (Q1 2025).
- Year-over-year, Interest & Investment Income has declined for three consecutive quarters, with growth averaging 70.6% over the last eight quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2023 (growth of 956.0%), and the weakest in Q3 2021 (a decline of 80.3%).
- Business Quant data shows CRNX's Interest & Investment Income at $12.66 million (Q1 2026), $11.16 million (Q4 2025) and $12.54 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | 12.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.03 Mn |
| Mar 31, 2026 | 12.66 Mn |
| Dec 31, 2025 | 11.16 Mn |
| Sep 30, 2025 | 12.54 Mn |
| Jun 30, 2025 | 13.46 Mn |
| Mar 31, 2025 | 14.83 Mn |
| Dec 31, 2024 | 14.37 Mn |
| Sep 30, 2024 | 11.01 Mn |
| Jun 30, 2024 | 8.74 Mn |
| Mar 31, 2024 | 7.32 Mn |
| Dec 31, 2023 | 6.72 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 1.90 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 720,000.00 |
| Mar 31, 2022 | 193,000.00 |
| Dec 31, 2021 | 80,000.00 |
| Sep 30, 2021 | 24,000.00 |
API Access
Crinetics Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();